Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024943 · ClinicalTrials.gov registry record
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
A clinical trial of Heart Failure, sponsored by Medtronic.
- Active
- Registry status
- 1,092
- Enrollment target
- 20
- Study locations
NCT04024943 is a study of Heart Failure that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 1,092 participants, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (47% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT04024943, a study of Heart Failure, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,092 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this Post-Approval Study (PAS) is to evaluate the long-term performance of the Model 4798 Left Ventricular (LV) lead in a real-world patient population. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the Model 4798 LV lead and is integrated within the Product Surveillance Registry (PSR).
Conditions Studied
Interventions
- DEVICE Quadripolar LV Lead
Study Locations (20)
Florida
- Clearwater Cardiovascular Consultants - Clearwater
- Heart Rhythm Solutions - Hollywood
- Baptist Health - Jacksonville
- Cardiovascular Institute of Northwest Florida - Panama City
- Heart & Vascular Institute of Florida - Safety Harbor
- Heart Rhythm Consultants P.A. (Sarasota Memorial Research) - Sarasota
California
- Chula Vista Cardiac Center - Chula Vista
- San Diego Arrhythmia Associates - San Diego
- COR Healthcare - Torrance
- Cardiovascular Consultants Medical Group (Van Nuys) - Van Nuys
- Cardiology Associates Medical Group - Ventura
Colorado
- Colorado Springs Cardiology - Colorado Springs
- Denver Heart - Denver
- Colorado Heart and Vascular - Lakewood
Arkansas
- Cardiology Associates of Northeast Arkansas - Jonesboro
- Saint Vincent Heart Clinic Arkansas - Little Rock
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Haven
Alaska
- Alaska Heart - Anchorage
Arizona
- Southwest EP - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,092 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04024943
The ClinicalTrials.gov registry entry for NCT04024943 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,092 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (47% lower). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Quadripolar LV Lead is the first listed.
NCT04024943 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04024943 about?
NCT04024943 is a clinical study titled "Personalized Therapy Study - Attain Stability Quad Post-Approval Study". The purpose of this Post-Approval Study (PAS) is to evaluate the long-term performance of the Model 4798 Left Ventricular (LV) lead in a real-world patient population. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the Model 4798 LV...
What is the current status of trial NCT04024943?
This trial is currently active not recruiting. The enrollment target is 1,092 participants. The study started on 2017-08-21. Estimated completion is 2028-01.
What conditions does trial NCT04024943 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04024943?
The interventions under investigation include: Quadripolar LV Lead (DEVICE).
Who is sponsoring clinical trial NCT04024943?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04024943 being conducted?
This trial has 20 study locations across Alaska, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.